Kairos Pharma KAPA
NYSE KAPA
$0.55 -0.02 (-3.90%)
As of: Oct 22, 2026 · 10:10 AM EDT

Kairos Pharma (KAPA) Other financing activities (2023 - 2024)

Updated

Kairos Pharma (KAPA) recorded Other financing activities of $390,000 in FY2024, down 8.2% from $425,000 in FY2023.

Analysis

Kairos Pharma (KAPA) Other financing activities (2023 - 2024) Analysis & Trends

  • Per Business Quant data, KAPA's Other financing activities was $425,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,164.71 Bn 1,133.30 Bn 19.71 Bn
2 Johnson & Johnson 633.37 Bn 551.90 Bn 17.26 Bn
3 AbbVie 503.99 Bn 477.10 Bn 12.70 Bn
4 Merck 378.19 Bn 332.57 Bn 12.21 Bn
5 Novartis Ag 303.15 Bn 267.14 Bn 11.24 Bn
6 Astrazeneca 266.17 Bn 239.85 Bn 12.86 Bn
7 Amgen 241.38 Bn 196.78 Bn 7.24 Bn
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn
10 Kairos Pharma 10.21 Mn -2.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -348,000.00
Jun 30, 2024 47,000.00
Mar 31, 2024 -89,000.00
Dec 31, 2023 -72,000.00
API Access

Kairos Pharma Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=KAPA&period=max&api_key=YOUR_API_KEY